Analyst William Tanner Angles for TherapeuticsMD to Secure a Late 2018 Approval in VVA
As TherapeuticsMD Inc (NASDAQ:TXMD) shares take off to the rocket fuel tune of 35%, Cantor analyst William Tanner bullishly backs soaring investor sentiment.
Story Continues
